A personalised cancer vaccine moves another step closer. A late-stage trial of an mRNA vaccine tailored to each patient’s tumour has shown it can reduce the risk of melanoma returning or spreading.

A personalised cancer vaccine moves another step closer. A late-stage trial of an mRNA vaccine tailored to each patient’s tumour has shown it can reduce the risk of melanoma returning or spreading.
Thank you, Olly, for raising almost £16,300 for Melanoma Focus to help support those affected by melanoma. An incredible amount!
You can still support Olly’s fundraiser HERE: bit.ly/4z4dbVx
For Bill💙
#MelanomaFocus #Fundraising #Melanoma
(2/2)